United Therapeutics Corporation
Extract: Discloses AGM Date
from a
10-K
on 02/21/2024
Download
SEC Document
SEC Filing
Portions of the registrant’s definitive proxy statement for the registrant’s 2024 annual meeting of shareholders scheduled to be held on June 26, 2024, are incorporated by reference in Part III of this Form 10-K.